Clinical-grade biologics trusted by leading practitioners
End-to-end manufacturing of 3D-cultured UCT-MSC biologics designed to deliver consistent secretome output, verified exosome content, and clinically reliable performance. Built on controlled bioreactor systems and analytical validation, our platform supports reproducibility, traceability, and confidence in clinical use.
Xeno-Free
No animal-derived components. Reduced biologic risk, improved consistency.
3D Culture · 20x Potency
Bioreactor-grown with up to 19.4x higher yield vs. standard 2D methods.
98% Post-Thaw Viability
Validated cryopreservation preserves cellular integrity and consistent dosing.
Ethically Sourced UCT-MSCs
AATB-accredited. FDA Type II Master File. 3-generation donor screening.
Wharton's Jelly UCT-MSCs
Biologically younger, highly proliferative, and naturally immune-privileged.
Live Cryopreserved · Never Lyophilized
Native membranes preserved. No freeze-drying that degrades bioactivity.
Multipotent UCT-MSCs
Differentiates into bone, cartilage, muscle, and connective tissue lineages.
Third-Party Tested · Full Traceability
NTA-verified particle count and lot-specific COAs on every batch.
Built for Safe, Reliable Results. Trusted by Clinics Worldwide
STEM Nova ethically produces and independently tests U.S.-made 3D UCT‑MSCs and Exosome+™ in our cGMP‑certified facility, delivering clinical‑grade cells and exosomes with unmatched potency, safety, viability, and full regulatory compliance for clinics and research teams.
FAQs
We’ve compiled answers to the most common inquiries about our stem cell and exosome products, from safety and usage to regulatory compliance and clinical applications.
Are STEM Nova Network biologics FDA‑approved?
No. Our 3D UCT‑MSC and exosome products are manufactured in FDA‑registered, ISO‑compliant facilities under cosmetic good‑manufacturing practices, but they are not FDA‑approved drugs or biologics. The U.S. Food and Drug Administration states that exosome products intended to treat diseases or conditions in humans require FDA approval and “there are currently no FDA‑approved exosome products”. We strictly market our products for research or topical cosmetic use and do not make medical claims.
What makes 3D‑cultured MSCs better than traditional 2D?
Three‑dimensional culture mimics the body’s natural environment and dramatically increases exosome production and potency. In a hollow‑fiber 3D bioreactor, MSCs produced up to 19.4‑fold more exosomes than in a standard 2D flask, and the supernatants were 15.5‑fold more concentrated. 3D culture also allows continuous harvesting of exosomes, requires far fewer plastic flasks and less labour, and can produce an equivalent yield in less than 30 minutes per day. These 3D‑derived exosomes show superior uptake by target cells and stronger effects .compared with 2D exosomes.
These 3D-derived exosomes demonstrate superior biological signaling profiles and cellular uptake characteristics compared with 2D exosomes, supporting the enhanced potency behind our 3DExo+™ platform
Can I inject these biologics?
Stem Nova biologics are manufactured to pharmaceutical-grade quality standards, including sterility, endotoxin, and viability testing. They are labeled for topical and research use only. Any clinical application is at the sole discretion and professional responsibility of the licensed practitioner, in accordance with all applicable federal and state regulations.
Who are Stem Nova's products intended for?
Stem Nova biologics are supplied exclusively to licensed medical professionals. How products are used within a practitioner's clinical protocols is at their sole discretion and in accordance with applicable federal and state regulations. We do not advise on indications, applications, or patient protocols.
What does “xeno‑free ”mean?
“Xeno‑free” means that all components are derived from the same species (human) or are recombinant, so no animal‑derived ingredients such as fetal bovine serum are present. RegMedNet explains that xeno‑free media contain only proteins of human origin or recombinant quality. Using xeno‑free, serum‑free manufacturing reduces the risk of introducing foreign proteins or pathogens, making the product safer and more consistent for cosmetic or research use.
The Next Competitive Advantage in Human Performance
From elite athletes to advanced clinical applications, the future belongs to regenerative medicine.
Stem Nova develops and delivers validated, clinical-grade biologics through rigorously controlled processes—built for those who demand measurable outcomes and uncompromising quality.
Disclaimer
Stem Nova Network supplies professional-grade, cell-free biologic matrices exclusively to licensed medical professionals. These products are not FDA-approved drugs or therapeutic agents and are not intended to diagnose, treat, cure, or prevent any disease or condition. No exosome or MSC-derived biologic product currently holds FDA approval for therapeutic use in humans.
All product use is at the sole clinical discretion and professional responsibility of the licensed practitioner. Stem Nova Network does not provide medical advice, clinical protocols, or treatment guidance of any kind.
